Senior Medical Director, Clinical Development
Core
Lead medical and scientific leadership for late-phase solid tumor clinical development, specifically the VS-7375 KRAS G12D ON/OFF inhibitor program, overseeing Phase 3 pivotal trials and regulatory filings.
Role type
Senior Medical Director, Clinical Development
Builds
Oncology drugs targeting RAS/MAPK pathway mutations for solid tumors
Domain
Oncology / Biotechnology
Required skills
Medical degree (MD), late-phase oncology trial leadership, Phase 3 pivotal study design and execution, regulatory submission authoring (NDA/MAA), medical monitoring, safety signal characterization, benefit-risk assessment, protocol interpretation, cross-functional collaboration
Preferred skills
Experience with CRO management, health authority interactions, investigator relations, scientific presentation
Technologies
None stated
Responsibilities
Lead design and medical execution of late-phase solid tumor trials; serve as primary medical monitor and contact; oversee safety and efficacy data review; author protocols, clinical study reports, and regulatory submission sections; contribute to NDA/MAA preparation and filing; partner with regulatory affairs for health authority meetings; build relationships with investigators and key opinion leaders
Seniority
Senior, hands-on IC